What is ADMA Biologics's inventory write-downs?

ADMA Biologics (ADMA) reported inventory write-downs of $2.1M in Q2 2023.

What does inventory write-downs mean?

The reduction in the carrying value of inventory due to obsolescence, spoilage, or market value falling below cost. This serves as an indicator of inventory management efficiency and potential quality control issues.

ADMA Biologics ADMA Inventory write-downs

Inventory write-downs at other companies

TG TherapeuticsTGTX

$1.54M—

Adaptive BiotechnologiesADPT

-$10K+90.1%

Charles River LaboratoriesCRL

$1.49M-78.0%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's inventory write-downs?: ADMA Biologics (ADMA) reported inventory write-downs of $2.1M in Q2 2023.
What does inventory write-downs mean?: The reduction in the carrying value of inventory due to obsolescence, spoilage, or market value falling below cost. This serves as an indicator of inventory management efficiency and potential quality control issues.